Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up-Reference-Cited by-同舟云学术

Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up

Published:2016-02 Issue:3 Volume:1 Page:284-290
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Dagher Julien,Kammerer-Jacquet Solène-Florence,Brunot Angélique,Pladys Adélaide,Patard Jean-Jacques,Bensalah Karim,Perrin Christophe,Verhoest Grégory,Mosser Jean,Lespagnol Alexandra,Vigneau Cécile,Dugay Frédéric,Belaud-Rotureau Marc-Antoine,Rioux-Leclercq Nathalie

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs,2004

2. Mutations of the VHL tumour suppressor gene in renal carcinoma;Gnarra;Nat Genet,1994

3. Role of VHL gene mutation in human cancer;Kim;J Clin Oncol,2004

4. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma;Barnabas;J Surg Oncol,2002

5. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma;Kaelin;Clin Cancer Res,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC;2024-05-10

2. Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor–based Combinations;European Urology Focus;2024-04

3. The von Hippel-Lindau protein forms fibrillar amyloid assemblies that are mitigated by the anti-amyloid molecule Purpurin;Biochemical and Biophysical Research Communications;2024-01

4. A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma;Molecular Oncology;2023-04-18

5. New splice variants of VEGF as relevant targets for the treatment of renal cell carcinoma;2022-11-07